Drazba Brian G. 4
4 · ISTA PHARMACEUTICALS INC · Filed Jun 15, 2012
Insider Transaction Report
Form 4
Drazba Brian G.
VP, Finance & CAO
Transactions
- Disposition to Issuer
Option (right to buy)
2012-06-06−1,940→ 0 totalExercise: $3.75Exp: 2021-11-30→ Common Stock (1,940 underlying) - Disposition to Issuer
Option (right to buy)
2012-06-06−8,500→ 0 totalExercise: $4.58Exp: 2020-12-16→ Common Stock (8,500 underlying) - Disposition to Issuer
Option (right to buy)
2012-06-06−7,875→ 0 totalExercise: $3.71Exp: 2019-06-22→ Common Stock (7,875 underlying) - Disposition to Issuer
Common Stock
2012-06-06$9.10/sh−40,487$368,432→ 0 total - Disposition to Issuer
Option (right to buy)
2012-06-06−29,935→ 0 totalExercise: $3.75Exp: 2021-11-30→ Common Stock (29,935 underlying) - Disposition to Issuer
Option (right to buy)
2012-06-06−5,828→ 0 totalExercise: $3.63Exp: 2020-02-02→ Common Stock (5,828 underlying) - Disposition to Issuer
Option (right to buy)
2012-06-06−4,834→ 0 totalExercise: $4.58Exp: 2020-12-16→ Common Stock (4,834 underlying)
Footnotes (6)
- [F1]Disposed of pursuant to agreement and plan of merger by and among the Company, Bausch & Lomb Incorporated and Inga Acquisition Corporation, as amended (the "Merger Agreement") in exchange for $9.10 per share, without interest, less any applicable withholding tax, on the effective date of the merger.
- [F2]The option which was unvested was cancelled in the merger in exchange for a cash payment equal to $5.35 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10).
- [F3]The option of which 4,683 shares were unvested and 151 shares were vested and were cancelled in the merger in exchange for a cash payment equal to $4.52 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10).
- [F4]The option of which 8,235 shares were unvested and 265 shares were vested and were cancelled in the merger in exchange for a cash payment equal to $4.52 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10).
- [F5]The option which was unvested was cancelled in the merger in exchange for a cash payment equal to $5.47 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10).
- [F6]The option of which 7,313 shares were unvested and 562 shares were vested and were cancelled in the merger in exchange for a cash payment equal to $5.39 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10).